StockTipsArenaBeta

BUY Huhtamaki India Limited — Aastha Jain, Hem Securities

BUYHuhtamaki India Limited
Huhtamaki India share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: NA (inferred Swing (≤2wk))22 Jul 2026via Zee Business (Live)

Entry₹270.29Inferred
Target₹290
Total upside +7.29% (call closed)
Stop loss₹244-9.73% risk
Exit₹29022 Jul 2026, 9:35 am
Target hit+7.29%0.00%upside left
Follow Aastha Jain for new calls(30% target hit, 80 closed calls)Get alertsWatch HUHTAMAKI for new buy/sell callsGet alertsSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
4 supporting1 neutral0 opposing
Supports the BUY call (4)

Concurrent Gainers: 12 smallcap stocks that gain for 5 days in a row

NewsEt-Markets·25 Jul · 1w ago

(opens in new tab)

Concurrent Gainers: 12 smallcap stocks that gained for 5 days in a row

NewsEt-Markets·25 Jul · 1w ago

(opens in new tab)

Huhtamaki India reported Q2 2026 results with net sales of Rs. 7,286 million (up 23.1% YoY) and EBIT before exceptional items of Rs. 622 million (up 71.8% YoY). H1 2026 also showed growth in net sales

NSE · Press Release·21 Jul · 2w ago

(opens in new tab)

Huhtamaki India reported Q2 2026 results with net sales of Rs. 7,286 million (up 23.1% YoY) and EBIT before exceptional items of Rs. 622 million (up 71.8% YoY). H1 2026 saw net sales of Rs. 13,222 mil

BSE · Company Update·21 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Huhtamaki India Ltd announced the approval of its unaudited financial results for the second quarter and six months ended June 30, 2026, along with a Limited Review Report from the auditors.

BSE · Board Meeting·21 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Huhtamaki India

All analyst calls on Huhtamaki India

More from Aastha Jain, Hem Securities

Every call and its outcome